ALZN Financials

Alzamend Neuro Inc - Financial statements & key metrics

Stock Price

$2.14

Market Cap

$7.99M

EPS

$-2.67

Income Statement Highlights

Most Recent Quarter: FY

Revenue

Gross Profit

Operating Income

$-4.50M

Net Income

$-4.51M

EPS (Diluted)

$-11.32

Balance Sheet Highlights

Total Assets

$4.60M

Total Liabilities

$634,761

Shareholders Equity

$3.97M

Cash & Equivalents

$3.95M

Total Debt

Cash Flow Highlights

Operating Cash Flow

$-6.57M

CapEx

Free Cash Flow

Profitability Metrics

ROE

-1.4%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is ALZN revenue?

View ALZN's income statement for detailed revenue data.

Is ALZN profitable?

ALZN reported a loss of $4.51M in the most recent quarter.

What is ALZN market cap?

ALZN has a market capitalization of $7.99M, making it a small-cap stock.

Does ALZN have debt?

View ALZN's balance sheet for debt information.

What is ALZN cash flow?

Cash flow data is available in the full financial statements.